Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Y Chen

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Head and Neck Pathology|July 25, 2013
Acetylated tubulin (AT) as a prognostic marker in squamous cell carcinoma of the head and neckNabil F Saba, Kelly R Magliocca, Sungjin Kim, et al.
Oncoimmunology|June 18, 2024
CD28-CD57+ T cells from head and neck cancer patients produce high levels of cytotoxic granules and type II interferon but are not senescentBrendan L C Kinney, Brianna Brammer, Vikash Kansal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2020
Phase Ib Study of Chemoprevention with Green Tea Polyphenon E and Erlotinib in Patients with Advanced Premalignant Lesions (APL) of the Head and NeckDong M Shin, Sreenivas Nannapaneni, Mihir R Patel, et al.
Head & Neck|June 3, 2021
Perioperative pain management and opioid-reduction in head and neck endocrine surgery: An American Head and Neck Society Endocrine Surgery Section consensus statementJay K Ferrell, Maisie L Shindo, Brendan C Stack, et al.
Cancer|August 9, 2014
Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neckNabil F Saba, Selwyn J Hurwitz, Kelly Magliocca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2013
Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studiesDong M Shin, Hongzheng Zhang, Nabil F Saba, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 3, 2013
Chemoprevention of head and neck cancer with celecoxib and erlotinib: results of a phase ib and pharmacokinetic studyNabil F Saba, Selwyn J Hurwitz, Scott A Kono, et al.
Head & Neck|September 26, 2017
Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinomaHongzheng Zhang, Sungjin Kim, Zhengjia Chen, et al.
Head & Neck|March 9, 2022
Pediatric intraoperative nerve monitoring during thyroid surgery: A review from the American Head and Neck Society Endocrine Surgery Section and the International Neural Monitoring Study GroupGillian R Diercks, Jeff C Rastatter, Ken Kazahaya, et al.
The Laryngoscope|October 7, 2018
International neuromonitoring study group guidelines 2018: Part II: Optimal recurrent laryngeal nerve management for invasive thyroid cancer-incorporation of surgical, laryngeal, and neural electrophysiologic dataChe-Wei Wu, Gianlorenzo Dionigi, Marcin Barczynski, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Head and Neck Pathology|July 25, 2013
Acetylated tubulin (AT) as a prognostic marker in squamous cell carcinoma of the head and neckNabil F Saba, Kelly R Magliocca, Sungjin Kim, et al.
Oncoimmunology|June 18, 2024
CD28-CD57+ T cells from head and neck cancer patients produce high levels of cytotoxic granules and type II interferon but are not senescentBrendan L C Kinney, Brianna Brammer, Vikash Kansal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2020
Phase Ib Study of Chemoprevention with Green Tea Polyphenon E and Erlotinib in Patients with Advanced Premalignant Lesions (APL) of the Head and NeckDong M Shin, Sreenivas Nannapaneni, Mihir R Patel, et al.
Head & Neck|June 3, 2021
Perioperative pain management and opioid-reduction in head and neck endocrine surgery: An American Head and Neck Society Endocrine Surgery Section consensus statementJay K Ferrell, Maisie L Shindo, Brendan C Stack, et al.
Cancer|August 9, 2014
Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neckNabil F Saba, Selwyn J Hurwitz, Kelly Magliocca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2013
Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studiesDong M Shin, Hongzheng Zhang, Nabil F Saba, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 3, 2013
Chemoprevention of head and neck cancer with celecoxib and erlotinib: results of a phase ib and pharmacokinetic studyNabil F Saba, Selwyn J Hurwitz, Scott A Kono, et al.
Head & Neck|September 26, 2017
Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinomaHongzheng Zhang, Sungjin Kim, Zhengjia Chen, et al.
Head & Neck|March 9, 2022
Pediatric intraoperative nerve monitoring during thyroid surgery: A review from the American Head and Neck Society Endocrine Surgery Section and the International Neural Monitoring Study GroupGillian R Diercks, Jeff C Rastatter, Ken Kazahaya, et al.
The Laryngoscope|October 7, 2018
International neuromonitoring study group guidelines 2018: Part II: Optimal recurrent laryngeal nerve management for invasive thyroid cancer-incorporation of surgical, laryngeal, and neural electrophysiologic dataChe-Wei Wu, Gianlorenzo Dionigi, Marcin Barczynski, et al.
Pageof 12